A2A Pharmaceuticals, 10% Owner of Biomea Fusion BMEA, has filed 0 purchases and 8 sales on the open market. The latest trade was on 23/06/01.

AP

AP

A2A Pharmaceuticals

10% Owner

Company

Biomea Fusion BMEA

First filing

23/06/02

Trades

8 trades

Buys / sales

0 / 8

12-month net buying

No record

Last trade

23/06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Biomea FusionBMEA	Open-market sale	23/05/31–23/06/01	23/06/02	125,000 sh2 trades	$34.11avg.	$4,263,750	−3.4%
Biomea FusionBMEA	Open-market sale	23/05/12	23/05/17	25,000 sh	$33.84	$846,000	−0.7%
Biomea FusionBMEA	Open-market sale	23/05/08–23/05/09	23/05/10	250,000 sh2 trades	$34.30avg.	$8,574,000	−6.4%
Biomea FusionBMEA	Open-market sale	23/04/20	23/04/26	200,000 sh	$29.12	$5,824,000	−4.9%
Biomea FusionBMEA	Open-market saleAmendment	23/03/31	23/04/06	400,000 sh2 trades	$31.25avg.	$12,500,000	No record